- Home
- BARK vs NYXH Comparison
BARK vs NYXH Comparison
Compare BARK & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BARK
- NYXH
- Stock Information
- Founded
- BARK 2011
- NYXH 2009
- Country
- BARK United States
- NYXH Belgium
- Employees
- BARK N/A
- NYXH N/A
- Industry
- BARK Department/Specialty Retail Stores
- NYXH Medical/Dental Instruments
- Sector
- BARK Consumer Discretionary
- NYXH Health Care
- Exchange
- BARK Nasdaq
- NYXH Nasdaq
- Market Cap
- BARK 308.9M
- NYXH 261.1M
- IPO Year
- BARK N/A
- NYXH 2021
- Fundamental
- Price
- BARK $1.89
- NYXH $8.89
- Analyst Decision
- BARK Buy
- NYXH Strong Buy
- Analyst Count
- BARK 2
- NYXH 5
- Target Price
- BARK $2.20
- NYXH $17.00
- AVG Volume (30 Days)
- BARK 1.1M
- NYXH 51.2K
- Earning Date
- BARK 02-05-2025
- NYXH 11-06-2024
- Dividend Yield
- BARK N/A
- NYXH N/A
- EPS Growth
- BARK N/A
- NYXH N/A
- EPS
- BARK N/A
- NYXH N/A
- Revenue
- BARK $488,881,000.00
- NYXH $5,668,079.00
- Revenue This Year
- BARK $3.23
- NYXH $37.10
- Revenue Next Year
- BARK $10.01
- NYXH $418.12
- P/E Ratio
- BARK N/A
- NYXH N/A
- Revenue Growth
- BARK N/A
- NYXH 32.65
- 52 Week Low
- BARK $0.74
- NYXH $4.00
- 52 Week High
- BARK $2.56
- NYXH $20.00
- Technical
- Relative Strength Index (RSI)
- BARK 45.84
- NYXH 70.78
- Support Level
- BARK $1.81
- NYXH $7.89
- Resistance Level
- BARK $1.94
- NYXH $8.37
- Average True Range (ATR)
- BARK 0.12
- NYXH 0.45
- MACD
- BARK -0.05
- NYXH 0.10
- Stochastic Oscillator
- BARK 15.69
- NYXH 81.80
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.